Evidence map›Paper›PMID 24695785›Full record

ArticlePloS one2014

Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk.

Matthew P Rowan, Sonya M Bierbower, Michael A Eskander, Kalina Szteyn, Elaine D Por, Ruben Gomez, Nicholas Veldhuis, Nigel W Bunnett, Nathaniel A Jeske

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Repeated Morphine Administration IncreasesBiomolecules & therapeutics · 2022
    Article
  7. Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Pituitary Hormones and Orofacial Pain.Frontiers in integrative neuroscience · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Molecular Pharmacology of δ-Opioid Receptors.Pharmacological reviews · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Matthew P RowanDepartment of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Sonya M BierbowerDepartment of Physiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Michael A EskanderDepartment of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Kalina SzteynDepartment of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Elaine D PorDepartment of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Ruben GomezDepartment of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Nicholas VeldhuisDepartments of Pharmacology and Medicine, Monash Institute of Pharmacological Sciences, Parkville, Victoria, Australia.
Nigel W BunnettDepartments of Pharmacology and Medicine, Monash Institute of Pharmacological Sciences, Parkville, Victoria, Australia.
Nathaniel A JeskeDepartment of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America; Department of Physiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
The University of Texas Health Science Center at San Antonio · US

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institutional Research Training GrantT32DE014318 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Kenneth M Hargreaves · 2002 to 2026
$12.1M
PATHOBIOLOGY OF OCCLUSIVE VASCULAR DISEASET32HL007446 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jean Chrisostome Bopassa · 1985 to 2026
$8.9M
Scaffolding the Transition to Chronic PainR01NS082746 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2013 to 2017
$1.7M
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATIONR01NS061884 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2008 to 2011
$1.3M
M-Type K+ Channels: In Vivo Neuroprotective Role during Cerebrovascular StroF32NS079148 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BIERBOWER, SONYA MARIE · 2012 to 2014
$171k
The Role of Oxidized Linoleic Acid Metabolites in NGF Induced Persistent PainF31NS083358 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ESKANDER, MICHAEL ANDREW · 2013 to 2014
$54k
NCATS NIH HHS UL1 TR001120NHLBI NIH HHS T32 HL007446NIDCR NIH HHS T32 DE014318NINDS NIH HHS F31 NS083358NINDS NIH HHS F32 NS079148NINDS NIH HHS F32NS079148NINDS NIH HHS R01 NS061884NINDS NIH HHS R01NS061884NINDS NIH HHS R01 NS082746NINDS NIH HHS R01NS082746
6 · The paper itself

Abstract

The transient receptor potential family V1 channel (TRPV1) is activated by multiple stimuli, including capsaicin, acid, endovanilloids, and heat (>42C). Post-translational modifications to TRPV1 result in dynamic changes to the sensitivity of receptor activation. We have previously demonstrated that β-arrestin2 actively participates in a scaffolding mechanism to inhibit TRPV1 phosphorylation, thereby reducing TRPV1 sensitivity. In this study, we evaluated the effect of β-arrestin2 sequestration by G-protein coupled receptors (GPCRs) on thermal and chemical activation of TRPV1. Here we report that activation of mu opioid receptor by either morphine or DAMGO results in β-arrestin2 recruitment to mu opioid receptor in sensory neurons, while activation by herkinorin does not. Furthermore, treatment of sensory neurons with morphine or DAMGO stimulates β-arrestin2 dissociation from TRPV1 and increased sensitivity of the receptor. Conversely, herkinorin treatment has no effect on TRPV1 sensitivity. Additional behavioral studies indicate that GPCR-driven β-arrestin2 sequestration plays an important peripheral role in the development of thermal sensitivity. Taken together, the reported data identify a novel cross-talk mechanism between GPCRs and TRPV1 that may contribute to multiple clinical conditions.

Indexed as

AnimalsArrestinsbeta-Arrestin 2beta-ArrestinsCells, CulturedEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Fluorescence Resonance Energy TransferFuransMaleMiceMice, Inbred C57BLMorphinePyronesReceptors, Opioid, muTRPV Cation Channels9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl esterArrb2 protein, mouseArrestinsbeta-Arrestin 2beta-ArrestinsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-FuransMorphinePyronesReceptors, Opioid, muTRPV1 protein, mouseTRPV Cation Channels

Identifiers

PMID24695785
PMCPMC3973553
OpenAlexW2070992272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.